Company: Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. : [MLNM
Loading...
(%)
]
]Friday, 9 May 2008 | Source: Reuters
Japan's Takeda Pharmaceutical Co Ltd
<4502.T> posted a 77 percent drop in quarterly operating profit
as it spent to boost its pipeline, and forecast a sharp fall in
annual income linked to the costs of its $8 billion-plus
purchase of Millennium Pharmaceuticals.
Friday, 9 May 2008 | Source: Reuters
Japan's Takeda Pharmaceutical Co Ltd
<4502.T> posted a 7.7 percent fall in annual operating profit
on Friday and forecast a sharp drop for the current year on
costs for its $8.8 billion purchase of U.S. biotech firm
Millennium Pharmaceuticals.
Friday, 9 May 2008 | Source: Reuters
TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd
<4502.T> posted a 7.7 percent fall in annual operating profit
on Friday and forecast a sharp drop for the current year on
costs for its $8.8 billion purchase of U.S. biotech firm
Millennium Pharmaceuticals.
Tuesday, 29 Apr 2008 | Source: The Associated Press
Millennium Pharmaceuticals and Takeda Pharmaceuticals said Tuesday the companies have cleared all regulatory waiting periods required for the $8.8 billion cash buyout.
Thursday, 10 Apr 2008 | Source: Reuters
Takeda Pharmaceutical said it would buy U.S. firm Millennium Pharmaceuticals for $8.8 billion to boost its cancer drug business, in the biggest overseas acquisition by a Japanese drug maker.
Friday, 28 Mar 2008 | Source: CNBC.com
Ahead of the weekend, CNBC asks the experts where investors should place their bets.
Posts |
COMPANY : Millennium
10 Apr 2008
Following are the day’s biggest winners and losers... Read More
10 Apr 2008
This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few... Read More
7 Jan 2008
Here's our Fast Money Final Trade... Read More
11 Dec 2007
Has Cramer's favorite biotech stock lost its swagger? Not so fast.... Read More
VIDEO | COMPANIES : Millennium Pharmaceuticals, Inc.
Investment opportunities in Russia, with John Connor, of Third Millennium Russia Fund, and Tim Seymour, of Seygem Asset ...
Expect to see another wave of weakness in financial stocks, says Benjamin Pedley, Managing Director and Head of Advisory...
CNBC's Mike Huckman discusses Amgen's performance with shareholders at the company's annual meeting
Ron Ianieri, chief options strategist at Options University believes a true U.S. recovery would be seen when the Nasdaq ...
NBC's Tel Aviv bureau chief Martin Fletcher gets unprecedented access to drug-maker Teva, an Israeli company with a mark...
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes